Zobrazeno 1 - 10
of 65
pro vyhledávání: '"W, Sikhondze"'
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini
Autor:
Alexander W. Kay, Kees Keus, A. Mafukidze, K Altaye, S Masuku, T Simelane, C Wawa, B Kerschberger, A Shabangu, T Gwitima, T. Dlamini, Jennifer Furin, W Sikhondze, F Hassen, N Dlamini, D Vambe, O Maha, Andrea A. Howard
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 24:1095-1102
SETTING: Since 2015, Eswatini has been scaling up bedaquiline (BDQ) and delamanid (DLM) based drug-resistant TB treatment regimens under programmatic conditions.OBJECTIVE: Identification of factors associated with treatment outcomes in patients recei
Low uptake of preventive interventions among malaria cases in Swaziland: towards malaria elimination
Autor:
K Makadzange, P. Owiti, E Geoffroy, TK Mengestu, Rony Zachariah, Sabelo Dlamini, N Dlamini, W Sikhondze, S Kunene, Z Zulu
Publikováno v:
Public Health Action. 8:S29-S33
Settings: Swaziland is striving to achieve sustainable malaria elimination. Three preventive interventions are vital for reaching this goal: 1) effective household utilisation of long-lasting insecticide nets (LLINs), 2) indoor residual spraying (IRS
Autor:
N Dlamini, P. Owiti, W Sikhondze, S Kunene, K Makadzange, Z Zulu, E Geoffroy, Rony Zachariah, Nyasatu Ntshalintshali
Publikováno v:
Public Health Action. 8:S8-S12
Background: Swaziland is one of the southern African countries that aim to eliminate malaria by 2020. In 2010, the country introduced an Immediate Disease Notification System (IDNS) for immediate reporting of notifiable diseases, including malaria. H
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W Sikhondze, SN Dlamini, C Gracia-Edwards, A Shabangu, T. Dlamini, Jennifer Furin, D Vambe, Kees Keus, K Kunene
Publikováno v:
Public Health Action. 7:240-242
Bedaquiline (BDQ) has been recommended by the World Health Organization for the treatment of multi-drug-resistant tuberculosis (MDR-TB) since 2013, but experience using the drug in high-burden, lower-income countries is limited and case studies are n
Autor:
Mahamadou Bassirou Souleymane, Betty Jingxuan Zhang, Christopher Kuaban, Nargiza Parpieva, Sarah K. Brode, Karin Weyer, Dick Menzies, Syed Kumail Abidi, Arnaud Trébucq, Alberto Piubello, Ernesto Jaramillo, Norbert Ndjeka, W Sikhondze, Armand Van Deun, Esther C. Casas, Francesca Conradie, Pei Zhi Li, Ann C. Miller, Rupak Singla, V Schwoebel, Mavluda Makhmudova, Jay Achar, Christoph Lange, Mourtala Mohamed Assao Neino, Jonathon R. Campbell, Giovanni Battista Migliori, Philipp du Cros, Bakyt Myrzaliev, Dennis Falzon, Kerri Viney, Gunta Dravniece, Zhiyi Lan, Didi Bang, J Noeske, Faiz Ahmad Khan, Andrea Benedetti, Aung Kya Jai Maug
Publikováno v:
European Respiratory Journal. 55:1901467
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB): a standardised regimen of 9–12 months (the “shorter regimen”) a
Autor:
P. Owiti, W Sikhondze, J Namboze, Sabelo Dlamini, S Kunene, S. Zhou, Z Zulu, Rose J. Kosgei, Anthony Reid, N. Mkhonta, K Makadzange
Objective: To assess adherence to malaria diagnosis and treatment guidelines (2010 and 2014) in all health care facilities in Swaziland between 2011 and 2015. Methods: This was a cross-sectional descriptive study involving all health care facilities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fb5ecb62df0de92fca44d169b1ee23
https://europepmc.org/articles/PMC5912419/
https://europepmc.org/articles/PMC5912419/
Autor:
Serge Ade, Anthony D. Harries, Sabelo Dlamini, Jesse Wambugu, T. Dlamini, Engy Ali, T. Zikalala, G. Maphalala, W. Sikhondze, Heidi Albert, Katie Tayler-Smith, D. Khumalo
Publikováno v:
Public Health Action. 5:140-146
Sputum smear microscopy remains the most widely used technology for the diagnosis of pulmonary tuberculosis (TB) in low- and middle-income countries. Although inexpensive to perform, smear microscopy is cumbersome, costly for patients, diagnostically
Autor:
Nicolas Veziris, Jennifer Hughes, W Sikhondze, Alena Skrahina, A Shabangu, N. Kiria, Norbert Ndjeka, Lorenzo Guglielmetti, Zaza Avaliani, Nino Lomtadze, S. Setkina, Cathy Hewison, Jennifer Furin
Publikováno v:
International Journal of Tuberculosis and Lung Disease
International Journal of Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, 2017, 21 (2), pp.167-174. ⟨10.5588/ijtld.16.0493⟩
International Journal of Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, 2017, 21 (2), pp.167-174. ⟨10.5588/ijtld.16.0493⟩
Background For the first time in almost 50 years, there are new drugs available for the treatment of tuberculosis (TB), including bedaquiline (BDQ) and delamanid (DLM). The rate of introduction, however, has not kept pace with patient needs. It is es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49295dba1e473e97a8704123d2c94252
https://hal.archives-ouvertes.fr/hal-02909465
https://hal.archives-ouvertes.fr/hal-02909465